Rep. Jared Moskowitz Purchases HCA Healthcare, Inc. (NYSE:HCA) Shares

Representative Jared Moskowitz (Democratic-Florida) recently bought shares of HCA Healthcare, Inc. (NYSE:HCA). In a filing disclosed on July 26th, the Representative disclosed that they had bought between $1,001 and $15,000 in HCA Healthcare stock on June 17th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 6/18/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Monster Beverage (NASDAQ:MNST) on 6/17/2026.
• Sold $1,001 – $15,000 in shares of S&P Global (NYSE:SPGI) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of SpaceX (NASDAQ:SPCX) on 6/12/2026.
• Sold $1,001 – $15,000 in shares of Cencora (NYSE:COR) on 5/6/2026.
• Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 5/6/2026.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $9.88 during mid-day trading on Wednesday, reaching $410.61. 504,417 shares of the company traded hands, compared to its average volume of 1,350,725. The firm has a market cap of $88.90 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 1.41 and a beta of 1.10. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a fifty day simple moving average of $387.44 and a 200-day simple moving average of $449.94.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company posted $6.84 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research analyst reports. Oppenheimer lowered their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Leerink Partners lowered their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. TD Cowen cut their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Royal Bank Of Canada restated an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Argus reduced their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $465.59.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently modified their holdings of the business. State Street Corp lifted its stake in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after acquiring an additional 76,039 shares in the last quarter. Capital World Investors lifted its position in HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares in the last quarter. Norges Bank acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.